Home > Products > CTLA4 & PD1
> Recombinant Anti-CTLA4 x Anti-PD1 Bispecific Antibody (scIgG)
Recombinant Anti-CTLA4 x Anti-PD1 Bispecific Antibody (scIgG) (CAT#: SCIGG-146)
Recombinant Anti-CTLA4 x Anti-PD1 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CTLA4 and anti-PD1 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can bind two factors simultaneously and enhance immune response. It is designed for the research of Tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CTLA4 x Anti-PD1 Bispecific Antibody (scIgG) (SCIGG-146). Click the button below to contact us or submit your feedback about this product.